Alzheimer's Disease - Researcher develops procedures for defining preclinical stages of Alzheimer's disease
Can't see this email? View it online
   
  Alzheimer's Disease  
  The latest Alzheimer's disease news from News Medical  
 Tau protein in Alzheimer's disease looks different at every dementia stageTau protein in Alzheimer's disease looks different at every dementia stage
 
Research into Alzheimer's disease has long focused on understanding the role of two key proteins, beta amyloid and the tau protein. Found in tangles in patients' brain tissue, a pathological form of the tau protein contributes to propagating the disease in the brain.
 
   Researcher develops procedures for defining preclinical stages of Alzheimer's diseaseResearcher develops procedures for defining preclinical stages of Alzheimer's disease
 
Both of Andrew Kiselica's grandfathers developed dementia when he was in graduate school. As Kiselica was going through neuropsychology training in graduate school, he saw his mother's father become unable to walk or speak due to severe dementia.
 
   Impaired blood flow to brain regions linked with tau buildup in Alzheimer’s diseaseImpaired blood flow to brain regions linked with tau buildup in Alzheimer’s disease
 
In Alzheimer’s disease, impaired blood flow to brain regions coincides with tau protein buildup. This relationship strengthens as cognition declines, according to new research published in JNeurosci.
 
 Anxiety may help to progress Alzheimer’s disease
 
Anxiety may help to progress Alzheimer’s diseaseThe results of a new study reveal the link between increased levels of anxiety and an elevated rate of progression to Alzheimer's disease.
 
 
 A new potential therapy for Alzheimer's disease
 
A new potential therapy for Alzheimer's diseaseA new potential therapeutic target for Alzheimer’s disease has been discovered by US researchers based at Case Western Reserve University.
 
 
 Researchers receive $2.6 million grant to examine tau-glycan interactions involved in Alzheimer's disease
 
Researchers receive $2.6 million grant to examine tau-glycan interactions involved in Alzheimer's diseaseTangles of misfolded tau proteins in the brain are closely associated with memory loss in patients with Alzheimer's disease.